Cite
MLA Citation
E. Senkus-Konefka et al.. “Subgroup analysis of olaparib monotherapy versus chemotherapy by hormone receptor and BRCA mutation status in patients with HER2-negative metastatic breast cancer and a germline BRCA mutation: OlympiAD.” European journal of cancer, vol. 92, n.d., pp. S19–S20. http://access.bl.uk/ark:/81055/vdc_100060771599.0x000031